-
- EXPLORE
-
-
-
-
-
-
-
Actualizaciones Recientes
-
Lenalidomide: Enhancing Efficacy in Hematologic MalignanciesLenalidomide, a derivative of thalidomide, has emerged as a cornerstone in the treatment of hematologic malignancies. As an immunomodulatory drug (IMiD), it exhibits potent anti-cancer, anti-inflammatory, and anti-angiogenic properties. Its efficacy has been well-documented in multiple myeloma (MM), myelodysplastic syndromes (MDS), and certain types of lymphoma. With continuous advancements in...0 Commentarios 0 Acciones 389 ViewsPlease log in to like, share and comment!
Quizás te interese…